Skip to content

Topical Anesthesia Versus Placebo to Decrease Pain in Rubber Band Ligation for Treatment of Internal Hemorrhoids

Topical Anesthesia Versus Placebo to Decrease Post Procedure Pain in Rubber Band Ligation for the Treatment of Grade I - III Symptomatic Internal Hemorrhoids. A Single Institution, Double Blinded, Placebo Controlled Trial.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02130830
Enrollment
80
Registered
2014-05-05
Start date
2014-05-31
Completion date
2016-05-31
Last updated
2016-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids, Pain

Keywords

hemorrhoids, Rubber band ligation, pain

Brief summary

Rubber band ligation is a simple and effective procedure for the management of hemorrhoidal disease. However, 90% of patients have some degree of discomfort associated with the procedure and up to 40% develop clinically significant pain. Some studies have used local anesthesia to reduce pain with promising results, but the use of topical anesthesia has not been reported before. The investigators hypothesize that the use of topical anesthesia before rubber band ligation significantly reduces post procedure pain.

Interventions

DRUGTopical 2,5% lidocaine + 2,5% prilocaine gel

The topical gel is administered in the anal canal at the moment of the anoscopy

DRUGPlacebo

Placebo gel to mimic topical anesthesia administered in the anal canal at the moment of the anoscopy

Sponsors

Pontificia Universidad Catolica de Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic grade I - III hemorrhoidal disease

Exclusion criteria

* Chronic liver disease * Use of class 3 antiarrythmics * Coagulopathy * Grade IV hemorrhoidal disease * Inflammatory bowel disease * Pregnancy

Design outcomes

Primary

MeasureTime frame
Pain measured in analog visual scaleup to 72 hours post procedure

Secondary

MeasureTime frame
Procedure morbidityup to 30 days post procedure

Other

MeasureTime frame
Pain measured in visual analog scale in subgroupsup to 72 hours

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026